Antiviral Drugs Flashcards
how does herpesviruses facilitate effective drug therapy?
- replication continues over long periods
- encode enzymes for their own replication
- participate in drug activation
two drugs used to prevent and treat influenza A, and the difference between them
- amantadine and oseltamivir
- amantadine is treatment and prophylaxis of influenza A ONLY, while oseltamivir is treatment and prevention of both influenza A and B
oseltamivir: use and mechanism
- prophylaxis and treatment of influenza A and B
- inhibits influenza neuraminidases and interferes with viral release and penetration
ophthalmic herpes simplex
trifluridine
herpes simplex not ophthalmic
acyclovir, foscarnet, famciclovir, penciclovir
acyclovir: use, mechanism
- systemic and genital herpes simplex
- activated by herpes enzymes and acts as a competitive inhibitor of dGTP and as a chain terminator
acute herpes zoster (shingles)
famciclovir
recurrent genital herpes
famciclovir
famciclovir: uses, mechanism
- acute herpes zoster (shingles), recurrent genital herpes
- mechanism similar to acyclovir, prodrug activated to penciclovir which is then phosphorylated to inhibit DNA polymerase
drugs that treat CMV infection
ganciclovir, foscarnet
ganciclovir: use, mechanism, side effect
- CMV retinitis and prophylaxis
- similar mechanism to acyclovir, nucleoside analog whose triphosphate form inhibits DNA synthesis and terminates DNA elongation
- bone marrow suppression
antiviral drugs that have bone marrow suppression as side effect
GRZ (bone marrow suppression is a GRiZzly side effect): ganciclovir, zidovudine (AZT), and ribavirin
acyclovir-resistant herpes simplex
foscarnet
foscarnet: uses, mechanism, side effects
- CMV, acyclovir-resistant herpes simplex
- inhibits DNA polymerase, does not require conversion to triphosphate form to be active
- side effects: renal damage, seizures (limits use)
drugs approved for hepatitis B and HIV
lamivudine and tenofovir
drugs used to treat hepatitis B
lamivudine, tenofovir, and alpha-interferons
mechanism of lamivudine and tenofovir when treating hepatitis B
inhibit reverse transcriptase domain of hepatitis B DNA polymerase
RSV infections (mostly children)
ribavirin